Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Advances in Cancer Research|July 2, 2022
Cardiac complications of cancer therapiesAdolfo G Mauro, Katherine Hunter, Fadi N SalloumAmerican Journal of Physiology. Heart and Circulatory Physiology|September 1, 2018
Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injuryStefano Toldo, Adolfo G Mauro, Zachary Cutter, et al.Journal of Cardiovascular Pharmacology|July 30, 2019
NLRP3 Inflammasome in Acute Myocardial InfarctionAdolfo G Mauro, Aldo Bonaventura, Eleonora Mezzaroma, et al.Journal of Molecular and Cellular Cardiology|November 20, 2025
Sphingosine-1-phosphate activates I<sub>Cl,swell</sub> in ventricular myocytes via mitochondrial reactive oxygen productionFrank J Raucci, Adolfo G Mauro, Edward J Lesnefsky, et al.JACC. Basic to Translational Science|February 7, 2022
Cardiac Gene Therapy With Relaxin Receptor 1 Overexpression Protects Against Acute Myocardial InfarctionTeja Devarakonda, Adolfo G Mauro, Chad Cain, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
INTERLEUKIN-18 AS A THERAPEUTIC TARGET FOR WESTERN DIET-INDUCED CARDIOMYOPATHYPratyush Narayan, Salvatore Carbone, Adolfo G Mauro, et al.Panminerva Medica|December 18, 2020
An update on the pathophysiology of acute and recurrent pericarditisAldo Bonaventura, Alessandra Vecchié, Adolfo G Mauro, et al.Cytokine|January 29, 2022
The interleukin-1 receptor type I promotes the development of aging-associated cardiomyopathy in micePratyush Narayan, Elefterios Trikantzopoulos, Eleonora Mezzaroma, et al.Biorxiv : the Preprint Server for Biology|July 3, 2026
Tumor-selective Mcl1 degradation by AUTAC uncouples antitumor efficacy from cardiotoxicityAhmed M Elshazly, Janakiram R Vangala, Adolfo G Mauro, et al.Scientific Reports|May 25, 2022
Chronic treatment with serelaxin mitigates adverse remodeling in a murine model of ischemic heart failure and modulates bioactive sphingolipid signalingTeja Devarakonda, Juan Valle Raleigh, Adolfo G Mauro, et al.Pageof 4